Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive

Jun Soo Kwon1, Yeon Ho Joo, Hee Jung Nam

  • 1Department of Neuropsychiatry, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.

Abstract

Insights

Genetic variations in the SLC1A1 gene are linked to atypical antipsychotic-induced obsessive-compulsive symptoms in schizophrenia patients. This study explores the genetic basis of these symptoms, offering insights into treatment mechanisms.

Area of Science:

  • Neuroscience
  • Pharmacogenetics
  • Psychiatry

Background:

  • Atypical antipsychotics (AAP) are known to induce obsessive-compulsive (OC) symptoms.
  • The underlying mechanisms remain largely unexplored.
  • Genetic association studies offer a viable approach to investigate the molecular basis of AAP-induced OC symptoms.

Purpose of the Study:

  • To investigate the association between polymorphisms in the glutamate transporter gene SLC1A1 and AAP-induced OC symptoms in schizophrenia patients.
  • To identify potential genetic markers for susceptibility to these adverse effects.

Main Methods:

  • A pharmacogenetic case-control association study was conducted.
  • Patients with schizophrenia receiving AAP treatment were analyzed (n=94).
  • Allele, genotype, and haplotype frequencies of SLC1A1 were assessed using logistic regression.

Main Results:

  • Trends of association were observed for specific SNPs (rs2228622, rs3780412) in the SLC1A1 gene.
  • A significant association was found for the A/C/G haplotype (rs2228622-rs3780413-rs3780412) with AAP-induced OC symptoms, which withstood multiple testing correction.
  • The odds ratio for the associated haplotype was 3.955.

Conclusions:

  • Sequence variations in SLC1A1 are associated with susceptibility to AAP-induced OC symptoms.
  • This is the first pharmacogenetic study to demonstrate this association.
  • Findings suggest the involvement of glutamatergic neurotransmission in the development of AAP-induced OC symptoms.

Related Concept Videos

Obsessive-Compulsive Disorder01:28

Obsessive-Compulsive Disorder

Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurrent obsessions, compulsions, or both, which consume significant time and interfere with daily functioning. Obsessions involve persistent, intrusive, and unwanted thoughts, images, or urges that evoke anxiety. Common examples include irrational fears of contamination or harm. Compulsions are repetitive behaviors or mental acts performed to reduce the anxiety caused by obsessions. For instance, individuals...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...